Sensei Biotherapeutics Appoints New CMO and Director
Ticker: SNSE · Form: 8-K · Filed: Sep 20, 2024 · CIK: 1829802
| Field | Detail |
|---|---|
| Company | Sensei Biotherapeutics, Inc. (SNSE) |
| Form Type | 8-K |
| Filed Date | Sep 20, 2024 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $360,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, board-appointment
TL;DR
Sensei Bio brings in new CMO and board member, signaling potential strategic shifts.
AI Summary
Sensei Biotherapeutics, Inc. announced on September 17, 2024, changes in its executive and director roles. Dr. John F. McDonald has been appointed as the new Chief Medical Officer, and Ms. Jennifer L. Jones has joined the Board of Directors. These appointments are part of the company's ongoing efforts to advance its pipeline of novel immunotherapies.
Why It Matters
The appointment of a new Chief Medical Officer and a Board member suggests a strategic shift or expansion in Sensei Biotherapeutics' leadership, potentially impacting its drug development and corporate strategy.
Risk Assessment
Risk Level: medium — Changes in key leadership roles can introduce uncertainty regarding future strategy and execution, impacting investor confidence.
Key Players & Entities
- Sensei Biotherapeutics, Inc. (company) — Registrant
- Dr. John F. McDonald (person) — Appointed Chief Medical Officer
- Ms. Jennifer L. Jones (person) — Appointed to Board of Directors
- September 17, 2024 (date) — Date of earliest event reported
FAQ
Who has been appointed as the new Chief Medical Officer?
Dr. John F. McDonald has been appointed as the new Chief Medical Officer.
Who has joined the Board of Directors?
Ms. Jennifer L. Jones has joined the Board of Directors.
What is the date of the earliest event reported in this 8-K filing?
The date of the earliest event reported is September 17, 2024.
What is the principal executive office address for Sensei Biotherapeutics, Inc.?
The principal executive office address is 1405 Research Blvd, Suite 125, Rockville, MD 20850.
What is the company's telephone number?
The company's telephone number is (240) 243-8000.
Filing Stats: 1,034 words · 4 min read · ~3 pages · Grade level 11.6 · Accepted 2024-09-20 16:31:04
Key Financial Figures
- $360,000 — ement provides for (i) a base salary of $360,000, (ii) an annual bonus target equal to 3
Filing Documents
- d881257d8k.htm (8-K) — 29KB
- 0001193125-24-222937.txt ( ) — 188KB
- snse-20240917.xsd (EX-101.SCH) — 4KB
- snse-20240917_def.xml (EX-101.DEF) — 14KB
- snse-20240917_lab.xml (EX-101.LAB) — 23KB
- snse-20240917_pre.xml (EX-101.PRE) — 15KB
- d881257d8k_htm.xml (XML) — 5KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Sensei Biotherapeutics, Inc. Date: September 20, 2024 /s/ Christopher W. Gerry Christopher W. Gerry General Counsel and Secretary 3